Your browser doesn't support javascript.
loading
Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis.
Gerboth, S; Frittoli, E; Palamidessi, A; Baltanas, F C; Salek, M; Rappsilber, J; Giuliani, C; Troglio, F; Rolland, Y; Pruneri, G; Kreutmair, S; Pallavicini, I; Zobel, M; Cinquanta, M; Minucci, S; Gomez, C; Santos, E; Illert, A L; Scita, G.
Afiliação
  • Gerboth S; Department of Molecular Oncology, IFOM Foundation, Institute FIRC of Molecular Oncology, Milan, Italy.
  • Frittoli E; Department of Molecular Oncology, IFOM Foundation, Institute FIRC of Molecular Oncology, Milan, Italy.
  • Palamidessi A; Department of Molecular Oncology, IFOM Foundation, Institute FIRC of Molecular Oncology, Milan, Italy.
  • Baltanas FC; Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca) and CIBERONC, Salamanca, Spain.
  • Salek M; Department of Molecular Oncology, IFOM Foundation, Institute FIRC of Molecular Oncology, Milan, Italy.
  • Rappsilber J; Department of Molecular Oncology, IFOM Foundation, Institute FIRC of Molecular Oncology, Milan, Italy.
  • Giuliani C; Department of Molecular Oncology, IFOM Foundation, Institute FIRC of Molecular Oncology, Milan, Italy.
  • Troglio F; Department of Molecular Oncology, IFOM Foundation, Institute FIRC of Molecular Oncology, Milan, Italy.
  • Rolland Y; Department of Molecular Oncology, IFOM Foundation, Institute FIRC of Molecular Oncology, Milan, Italy.
  • Pruneri G; European Institute of Oncology, Milano, Italy.
  • Kreutmair S; Department of Biosciences, University of Milan, Milan, Italy.
  • Pallavicini I; European Institute of Oncology, Milano, Italy.
  • Zobel M; Department of Molecular Oncology, IFOM Foundation, Institute FIRC of Molecular Oncology, Milan, Italy.
  • Cinquanta M; Cogentech S.c.a.r.l., at IFOM Via Adamello, Milan, Italy.
  • Minucci S; European Institute of Oncology, Milano, Italy.
  • Gomez C; Department of Biosciences, University of Milan, Milan, Italy.
  • Santos E; Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca) and CIBERONC, Salamanca, Spain.
  • Illert AL; Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca) and CIBERONC, Salamanca, Spain.
  • Scita G; Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany.
Leukemia ; 32(3): 820-827, 2018 03.
Article em En | MEDLINE | ID: mdl-28819285
ABSTRACT
Son of Sevenless 1 (SOS1) is a dual guanine nucleotide exchange factor (GEF) that activates the small GTPases RAC and RAS. Although the molecular mechanisms of RAS GEF catalysis have been unveiled, how SOS1 acquires RAC GEF activity and what is the physio-pathological relevance of this activity is much less understood. Here we show that SOS1 is tyrosine phosphorylated on Y1196 by ABL. Phosphorylation of Y1196 controls SOS1 inter-molecular interaction, is required to promote the exchange of nucleotides on RAC in vitro and for platelet-derived growth factor (PDGF) activation of RAC- and RAC-dependent actin remodeling and cell migration. SOS1 is also phosphorylated on Y1196 by BCR-ABL in chronic myelogenous leukemic cells. Importantly, in these cells, SOS1 is required for BCR-ABL-mediated activation of RAC, cell proliferation and transformation in vitro and in a xenograft mouse model. Finally, genetic removal of Sos1 in the bone marrow-derived cells (BMDCs) from Sos1fl/fl mice and infected with BCR-ABL causes a significant delay in the onset of leukemogenesis once BMDCs are injected into recipient, lethally irradiated mice. Thus, SOS1 is required for full transformation and critically contribute to the leukemogenic potential of BCR-ABL.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Proteínas de Fusão bcr-abl / Fatores de Troca do Nucleotídeo Guanina / Proteína SOS1 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Proteínas de Fusão bcr-abl / Fatores de Troca do Nucleotídeo Guanina / Proteína SOS1 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália